Protagonist Therapeutics (PTGX) Other Gross PP&E Adjustments (2017 - 2025)
Protagonist Therapeutics' Other Gross PP&E Adjustments history spans 9 years, with the latest figure at -$9.9 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 5324.74% year-over-year to -$9.9 million; the TTM value through Dec 2025 reached -$9.9 million, down 5324.74%, while the annual FY2025 figure was -$9.9 million, 5324.74% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$9.9 million at Protagonist Therapeutics, down from $2.2 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $5.8 million in Q4 2023 and bottomed at -$9.9 million in Q4 2025.
- The 5-year median for Other Gross PP&E Adjustments is $1.4 million (2022), against an average of $340500.0.
- The largest annual shift saw Other Gross PP&E Adjustments surged 753.37% in 2022 before it tumbled 5324.74% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $386000.0 in 2021, then soared by 753.37% to $3.3 million in 2022, then surged by 77.38% to $5.8 million in 2023, then tumbled by 96.75% to $190000.0 in 2024, then crashed by 5324.74% to -$9.9 million in 2025.
- Per Business Quant, the three most recent readings for PTGX's Other Gross PP&E Adjustments are -$9.9 million (Q4 2025), $2.2 million (Q3 2025), and $2.4 million (Q2 2025).